90 related articles for article (PubMed ID: 2910637)
1. Altered protein binding of etoposide in patients with cancer.
Stewart CF; Pieper JA; Arbuck SG; Evans WE
Clin Pharmacol Ther; 1989 Jan; 45(1):49-55. PubMed ID: 2910637
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients.
Stewart CF; Fleming RA; Arbuck SG; Evans WE
Cancer Res; 1990 Nov; 50(21):6854-6. PubMed ID: 2208152
[TBL] [Abstract][Full Text] [Related]
3. Changes in the clearance of total and unbound etoposide in patients with liver dysfunction.
Stewart CF; Arbuck SG; Fleming RA; Evans WE
J Clin Oncol; 1990 Nov; 8(11):1874-9. PubMed ID: 2230875
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting in vitro protein binding of etoposide in humans.
Fleming RA; Evans WE; Arbuck SG; Stewart CF
J Pharm Sci; 1992 Mar; 81(3):259-64. PubMed ID: 1640365
[TBL] [Abstract][Full Text] [Related]
5. Disposition of total and unbound etoposide following high-dose therapy.
Schwinghammer TL; Fleming RA; Rosenfeld CS; Przepiorka D; Shadduck RK; Bloom EJ; Stewart CF
Cancer Chemother Pharmacol; 1993; 32(4):273-8. PubMed ID: 8324869
[TBL] [Abstract][Full Text] [Related]
6. Etoposide pharmacokinetics in patients with normal and abnormal organ function.
Arbuck SG; Douglass HO; Crom WR; Goodwin P; Silk Y; Cooper C; Evans WE
J Clin Oncol; 1986 Nov; 4(11):1690-5. PubMed ID: 3772420
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma.
Aita P; Robieux I; Sorio R; Tumolo S; Corona G; Cannizzaro R; Colussi AM; Boiocchi M; Toffoli G
Cancer Chemother Pharmacol; 1999; 43(4):287-94. PubMed ID: 10071979
[TBL] [Abstract][Full Text] [Related]
8. Etoposide protein binding in cancer patients.
Liu B; Earl HM; Poole CJ; Dunn J; Kerr DJ
Cancer Chemother Pharmacol; 1995; 36(6):506-12. PubMed ID: 7554043
[TBL] [Abstract][Full Text] [Related]
9. Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.
Imbs DC; Paludetto MN; Négrier S; Powell H; Lafont T; White-Koning M; Chatelut E; Thomas F
Invest New Drugs; 2016 Feb; 34(1):41-8. PubMed ID: 26572909
[TBL] [Abstract][Full Text] [Related]
10. Protein binding of itraconazole and fluconazole in patients with cancer.
Arredondo G; Calvo R; Marcos F; Martínez-Jordá R; Suarez E
Int J Clin Pharmacol Ther; 1995 Aug; 33(8):449-52. PubMed ID: 8556224
[TBL] [Abstract][Full Text] [Related]
11. Variability in teniposide plasma protein binding is correlated with serum albumin concentrations.
Petros WP; Rodman JH; Relling MV; Christensen M; Pui CH; Rivera GK; Evans WE
Pharmacotherapy; 1992; 12(4):273-7. PubMed ID: 1518726
[TBL] [Abstract][Full Text] [Related]
12. Relationship of unbound bilirubin concentration to reserve albumin-binding concentration for bilirubin in human neonatal plasma.
Karp WB; Robertson AF; Davis HC
Biol Neonate; 1984; 46(3):105-9. PubMed ID: 6466747
[TBL] [Abstract][Full Text] [Related]
13. Bilirubin displaces furosemide from serum protein: the effect is greater in newborn infants than adult subjects.
Viani A; Pacifici GM
Dev Pharmacol Ther; 1989; 14(2):90-5. PubMed ID: 2630237
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer.
Liu X; Meng QH; Ye Y; Hildebrandt MA; Gu J; Wu X
Carcinogenesis; 2015 Feb; 36(2):243-8. PubMed ID: 25524924
[TBL] [Abstract][Full Text] [Related]
15. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
Zini R; Morin D; Salvadori C; Tillement JP
Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
[TBL] [Abstract][Full Text] [Related]
16. In vivo accumulation of etoposide in peripheral leukemic cells in patients treated for acute myeloblastic leukemia; relation to plasma concentrations and protein binding.
Liliemark EK; Liliemark J; Pettersson B; Gruber A; Björkholm M; Peterson C
Leuk Lymphoma; 1993 Jul; 10(4-5):323-8. PubMed ID: 8220130
[TBL] [Abstract][Full Text] [Related]
17. The binding of theophylline to serum proteins of hemodialysis patients.
Reidenberg MM; Restivo K
J Dial; 1979; 3(4):375-81. PubMed ID: 263959
[TBL] [Abstract][Full Text] [Related]
18. Plasma protein binding of frusemide in liver disease: effect of hypoalbuminaemia and hyperbilirubinaemia.
Viani A; Carrai M; Pacifici GM
Br J Clin Pharmacol; 1989 Aug; 28(2):175-8. PubMed ID: 2775623
[TBL] [Abstract][Full Text] [Related]
19. The effect of bile salts on the binding of bilirubin by plasma proteins.
Fulop M; Sandson J
Clin Sci; 1967 Dec; 33(3):459-69. PubMed ID: 6082605
[No Abstract] [Full Text] [Related]
20. Plasma protein binding of theophylline during development in the rabbit.
Aramayona JJ; Bonati M; Bortolotti A; Castelli D; Gaspari F; Lucchini G
Biol Neonate; 1991; 60(6):377-84. PubMed ID: 1797133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
